The amplitude and phase of the second harmonic (15 Hz) of the electroretinographic responses to three different spatial frequency grating stimuli (0.25, 1 and 4 c/deg), reversed at 7.5 Hz, were studied in normal human subjects, before and 30 min after the systemic administration of three doses (0.071, 0.357 or 1.428 mg/kg) of a selective D2 blocker, l-suipiride, to three populations of 18, 19 or 20 subjects. The effect of the drug on the pattern electroretinogram (PERG) was clearly dose-dependent, being greatest on the responses to 4 c/deg. The mean decrease in second harmonic amplitude was --13.8% after 0.071mg/kg of l-sulpiride, --23.5% after 0.357mg/kg and -28.5% after 1.428 mg/kg. The last two variations were significant at P < 0.01 and P < 0.01 respectively. These data suggest that a dose-dependent effect on the human retinal response to 4 c/deg stimuli exists, probably mediated by a coupling between l-sulpiride and D2 receptors. Lastly, our data suggest that D2 receptors may play an important role in the pathophysiology of visual dysfunction in Parkinson's disease, that has been described to be more significant at medium spatial frequency (2-5 c/deg).
INTRODUCTION
Dopaminergic cells have been described in the human retina (Borbe, Fehske, Muller, Nover & Wollert, 1982; Dearry, Falardeu, Shores & Caron, 1991; Denis, Elena, Nordmann, Saraux & Lapalus, 1990; Ehinger, 1982; Ehinger, 1983; Ehinger & Dowling, 1987; Frederick, Rayborn, Laties, Lam & Hollyfield, 1982; Zarbin, Wamsley, Palacios & Kuhar, 1986) and the presence of both of the two main receptor subtypes D1 and D2 has been reported (McGonigle, Wax & Molinoff, 1988; Schorderet & Nowak, 1990) . The electrophysiological effects of their selective activation or inactivation have been described in animals (Jensen, 1989 (Jensen, , 1992 Jensen & Daw, 1986; Ikeda, Robbins & Wakakuwa, 1987; Piccolino, Witkovsky & Trimarchi, 1987; Schneider & Zrenner, 1991; Witkovsky, Stone & Tranchina, 1989 human subjects, at relatively high doses, l-sulpiride, a selective D2 blocker, has been reported to reduce the amplitude of the retinal responses to steady-state grating reversal stimulation of coarse spatial frequencies (SFs) (Stanzione, Traversa, Pierantozzi, Semprini, Marciani & Bernardi, 1992) . A spatial frequency tuning alteration by l-sulpiride has also been reported recently in monkey (Tagliati, Bodis-Wollner, Kovanecz & Stanzione, 1994) . However, there is a lack of data about a dose-dependent effect of l-sulpiride, which could indicate specific coupling between antagonist and receptor, giving rise to a typical dose-response curve reaching the saturation level with an hyperbolic or sigrnoid shape. In order to investigate the specificity of l-sulpiride action on the retinal D2 receptors in humans, we studied the effects of three different doses (0.071, 0.357 and 1.428mg/kg, corresponding to 5, 25 and 100 mg of drug in a 70 kg subject) of the drug on the human PERG. The safety of human volunteers was considered when choosing the doses. Moreover, at each given dose we tested three different stimulus SFs in order to verify whether a dose-dependent effect is present only for a specific dimension of the visual stimulus. This could help to clarify the role of D2 receptors in the retinal dysfunction described in Parkinson's disease (PD) (for a review see Bodis-WoUner, 1990) 2659 2660 P. STANZIONE et al.
which has been described as a selective impairment of visual processing at medium SF (Bodis-Wollner, Marx, Mitra, Bobak, Mylin & Yahr, 1987) . Selective DI receptor antagonists are not currently available in clinical use, preventing the possibility to compare data concerning a possible complementary action of the two receptorial systems.
SUBJECTS AND METHODS
Seventy-six young, healthy volunteers [35 males and 41 females, mean age 28 yr _+ 5 yr (SD)] were involved in this study. They were colleagues, residents or personnel from the Neurological Clinic of our University. All participants were informed of the aim of the research and gave their informed consent. All had normal (20/25) or corrected-to-normal visual acuity. PERGs were recorded in one eye from each subject, sequentially stimulated by all three types of stimuli, before and 30 min (Reina, Sacchi & Aguggini, 1979 ) after a single dose of 0.071, 0.357 or 1.428 mg/kg of l-sulpiride i.m. (kindly supplied by Ravizza, Italy) or placebo. Nineteen subjects were treated with 0.071 mg/kg, 20 subjects with 0.357 mg/kg and 18 subjects with 1.428 mg/kg. Nineteen subjects were treated with placebo in order to obtain a reference group.
We studied the effects of increasing doses of l-sulpiride and placebo on the retinal responses evoked by low (0.25 c/deg, 11 °55' of visual angle, TV screen positioned at distance l l5cm), coarse (1 c/deg, 11"55' of visual angle, TV screen positioned at distance 115 cm) and medium (4 c/deg, 542' of visual angle, TV screen positioned at distance 240cm) SF square grating stimuli modulated at 7.5 Hz. PERGs were recorded by means of model 12A5 Grass amplifiers, amplified 50.000×, band-pass filtered at 1-100 Hz. Each recording was the average of 500 single trials of 500 msec, after having rejected any single trials contaminated by artifacts by means of an automatic window system (50/~V). Further details of the recording techniques have been published (Stanzione et al., 1992) . Fast Fourier transforms (FFT), by means of zero-padding (so that the frequency resolution was 1 Hz), were performed, and the power and phase of the second harmonic (15 Hz) taken into account. At least two recordings were performed for each SF. A phase stability (< 30 deg of phase difference) and a power of 15Hz double that at the adjacent harmonics (14 and 16 Hz) were considered to be signs of reliable potentials. The better recording was used in the statistical analysis.
All the data were analysed by means of a two-way ANOVA for each dose, utilizing the SFs (0.25, I and 4 c/deg) and drug administration (control and drug) as within factors. Moreover, an analysis for each SF was performed by means of a two-way ANOVA utilizing drug administration (control and drug) and drug doses (0.071, 0.357 and 1.429mg/kg) as within factors. Planned comparisons were performed in order to evaluate the significance of single differences between the retinal responses before and after/-sulpiride at different SFs. Student's t-test for paired samples, corrected with Bonferroni correction for multiple comparisons, was also performed in order to have a control test. Phase variations were analysed by means of Hotelling's t-test corrected for multiple comparisons (Zar, 1974) .
RESULTS
Nineteen subjects were recorded with the procedure described in the Methods, utilizing placebo injection to ensure stability of the recording method. None of the differences between control values and placebo administration were statistically significant by either the ANOVA analysis or Bonferroni-corrected Student's t-test. Only a significance of the main effect "SFs" in the ANOVA analysis was observed. Because of the smaller stimulated retinal area, PERG responses to 4 c/deg stimulation were smaller (Hess & Backer, 1984) , giving rise to a significance for the SF factor in the ANOVA analysis (d.f. 1/36, F =45.6, P < 0.0001).
The PERG data obtained from the subjects included in the study with l-sulpiride will be presented according to the administered dose of/-sulpiride (0.071, 0.357 or 1.428 mg/kg). Table 1 
O. 071 mg /kg
At the lowest dose used in this study /-sulpiride did not produce statistically significant variations of PERG responses, analysed with either Student's t-test or ANOVA (see Table 1 , 0.071 mg/kg row).
Because of the smaller stimulated retinal area, PERG responses to 4 c/deg stimulation were smaller (Hess & Backer, 1984) , giving rise to a significance for the SF factor in the ANOVA analysis (d.f. 1/18, F= 21.3, P < 0.0001).
0.357mg/kg
The dose of 0.357mg/kg induced a mean PERG amplitude variation very close to that producing a signifi~:ance for the factor "drug administration" in the ANOVA analysis (d.f. 1/19, F = 3.47, P = < 0.08) (see Table 1 , 0.357 mg/kg row). The planned comparison showed a highly significant amplitude decrease of the PERG response elicited by 4c/deg (d.f. 1/19, F= 8.4, P < 0.01) with the mean amplitude decreasing from 0.386 + 0.219/~V, to 0.295 + 0.217 ~tV, yielding a mean decrement of 23.5%. This decrement also was evident when analysed by the Student's t-test for paired samples (n = 20, t = 2.89, P < 0.01), corrected with Bonferroni (P < 0.05). The responses produced by the two other SFs did not change in a statistically significant way. The main effect of "SF" also was significant. None of the phase changes were statistically significant (see Table 1 ).
1.428mg/kg
l-Sulpiride at 1.428 mg/kg produced more significant effects than those found with the lower doses (see Table 1 , 1.428mg/kg row). The PERG response to 4 c/deg stimulation showed a mean amplitude decrease from 0.245 __ 0.102 /~V to 0.175_0.087~tV, with a mean percentage decrement of amplitude of -28.5%. The response to 1 c/deg also showed a decrease of the PERG mean amplitude from 0.489__+0.231/tV, to 0.340_0.160#V; the mean percentage decrement of amplitude was -30.4%. The PERG produced by 0.25 c/deg stimulation decreased from 0.533 ___ 0.169 #V to 0.497 _ 0.154/~V, with a main decrement of -6.75%0. ANOVA analysis showed that the main effect of the factor "drug application" was significant at the level of P < 0.01 (d.f. 1/17, F = 7.54). The planned comparisons showed no significant change of PERG response to 0.25c/deg stimulation (d.f. 1/17, F=0.9, P =n.s.), while the reductions of the responses to 1 and 4 c/deg were significant (d.f. 1/17, F = 6.24, P < 0.05 at 1 c/deg and d.f. 1/17, F= 12.3, P <0.01 at 4c/deg). Student's t-test for paired samples also showed a significant change of the response to 1 c/deg stimulation (n = 18, t = 2.49, P < 0.05) confirmed by Bonferroni correction (P<0.05). The same was observed for 4c/deg stimulation (Student's t-test, n = 18, t = 3.51, P < 0.01; Bonferroni P < 0.05). The main effect "SF" was also significant according to that reported above. None of the phase changes were statistically significant (see Table 1 ).
The two-way ANOVA analysis with "drug doses" (0.071, 0.357 and 1.428 mg/kg) as between factor and "drug administration" (control and drug) as within factor performed separately at each "SF", showed a significant decrease at l c/deg (d.f. 1/54, F=5.83, P < 0.05) and at 4 c/deg (d.f. 1/54, F = 20.14, P < 0.01). The drug administration effect was not significant at 0.025 c/deg. The significance levels are reported in the upper part of Table 1 .
DISCUSSION
The most important finding of this study is that l-sulpiride decreases the PERG responses to medium SF stimuli in a dose-dependent manner. Control data of the placebo group ensure the stability of these recordings and drug-related nature of the observed significant variations after l-sulpiride. The PERG evoked by 4 c/deg stimulus was the response most consistently affected by the different doses of l-sulpiride: -13.8%, -23.5% and -28.5% following administration of increasing doses. In order to verify whether these results depend on the specific coupling between the dopaminergic antagonist and the receptor, we tested our data with a theoretical FIGURE I. FFT traces from three different subjects before and after the administration of the reported three doses of l-sulpiride (left part). In each subject the retinal response to 0.25, 1 and 4 c/deg were recorded (columns). Each frame shows the response analysed by means of FFT. The computer is auto-scaling and the peak power is reported in the top-left of each frame.
dose response curve. Assuming that the effect of a dose lower than 0.071 mg/kg (e.g. 0.010mg/kg) can be considered null, our experimental PERG variations at 4c/deg, plus the extrapolated point at 0.010 mg/kg, should fit with an hyperbolic function after normalizing to the y =y/maximum value (Fig. 3) . Non-linear fits were performed on computed data by a family of hyperbolic functions following the equation y = A .(x /l + x ). Least-square estimation returns a value of 0.760 for the coefficient A and a global fit of 0.238. Because our results are fitted acceptably with an hyperbole, it is possible that the reduction of PERG response to 4 c/deg stimulation is mediated by a specific coupling between the antagonist and the D2 receptors.
The effect observed at l c/deg, already described (Stanzione et al., 1992) , was more variable in mean percentage change and statistically significant only with the highest dose (1.428 mg/kg). A grating stimulus with a square-wave profile does not contain all its power in a single spatial frequency, but also in the odd harmonics multiple of the basic frequency (Bodis-Wollner, Brannan, Ghilardi & Mylin, 1990) . Therefore part of the response may be evoked by SFs higher than the fundamental (i.e. in our case 3 or 5 c/deg). The observed reduction of l c/deg response could, therefore, be partially produced by the effect of /-sulpiride on the responses evoked by the higher spatial frequencies in the square-wave stimulus (i.e. 3 and 5 c/deg).
These findings suggest that D2 receptors are mainly located on retinal pathways (photoreceptor-bipolarganglion cell) mediating the response to medium SFs. Given the square profile of our stimulus, also odd harmonics, multiples of 4 c/deg (i.e. 12 c/deg) contain a significant power. Part of our PERG response to 4 c/deg stimulation could be produced by these harmonics. Human PERG response to SF higher than 10 c/deg is, however, reported to be negligible (Hess & Backer, 1984) . Virtually all of our PERG response to 4 c/deg can be considered to be produced by this medium SF, although we do not have data concerning possible variations at higher SF (i.e. 6--8 c/deg). Medium SF responses have been, however, described to be selectively altered in PD patients in psychophysical (Bodis-Wollner et al., 1987) and by retinal electrophysiological studies (Stanzione, PiereUi, Peppe, Stefano, Rizzo, Morocutti & Bernardi, 1989) . The reported selective impairment of PERG responses to 4 c/deg after l-sulpiride administration, suggests that the blockade of D2 receptors mimics the PD visual dysfunction. A study on the effects of D I selective antagonists would be very interesting. Unfortunately, flupentixol, the only clinically available drug with D1 antagonist activity, is not reported to be highly selective for D1 receptors (Tamminaga & Gerlach, 1987) . Data obtained with such a drug could be not conclusive. Our stimulator allows to perform 4 c/deg stimulation only by positioning the monitor at 2.4 m, thus reducing the stimulated retinal area from 11o55 ' to 5°42 ' . This reduction of the stimulated area to only the foveal region, may be an alternative explanation for the SF selectivity of the dose-dependent effect of l-sulpiride, explaining why it was observed only at 4 c/deg. Recent data concerning the in situ hybridization of mRNA for D2 receptors in the human retina have shown D2 receptors both in the inner and outer nuclear layers (Dearry et al., 1991) . Consistently dopamine (DA) fibres innervation in the human retina has been described as organized in both the plexiform layers (Frederick et al., 1982; Stormann, Gdula, Weiner & Brann, 1990) , or in two plexuses, one internal and the other external, both arranged in concentric zones (Savy, Simon & NguyenLegros, 1992) . Some authors, however, did not find DA fibres in the outer plexiform layer (Crooks & Kolb, 1992) . Aside from this layer distribution, not very much is known about possible different foveal and extrafoveal dopaminergic innervation in humans. Therefore, with the present knowledge, the anatomical data do not support or refute a topographic organization of dopaminergic D2 transmission able to selectively effect foveal responses. Our electrophysiological data seem to suggest that a specific action of D2 antagonist is present at least in the foveal region which, in our model, was selectively activated by the 4 c/deg stimulation. PERG responses produced by lower SF, originate mostly from extrafoveal regions where ganglion cells with larger receptive field are located. With regard to this knowledge, our electrophysiological data could be interpreted either as D2 transmission is located only on the "channels" conveying medium SF, independently from their location, either as D2 receptors are less present in more eccentric retinal area. The effect of a specific D2 antagonist on the responses originating from these areas will be expected to be very low, as observed in our study, with all the doses of /-sulpiride on the 0.25 c/deg induced responses.
